Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion type Assertion NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_head.
- NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion description "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_provenance.
- NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion evidence source_evidence_literature NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_provenance.
- NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion SIO_000772 15256482 NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_provenance.
- NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion wasDerivedFrom befree-20140225 NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_provenance.
- NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion wasGeneratedBy ECO_0000203 NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_provenance.